Assenagon Asset Management
REGN icon

Assenagon Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$222M Sell
423,325
-58,064
-12% -$30.5M 0.33% 60
2025
Q1
$305M Buy
481,389
+303,785
+171% +$193M 0.51% 25
2024
Q4
$127M Buy
177,604
+4,745
+3% +$3.38M 0.2% 81
2024
Q3
$182M Buy
172,859
+44,457
+35% +$46.7M 0.33% 45
2024
Q2
$135M Sell
128,402
-61,283
-32% -$64.4M 0.3% 54
2024
Q1
$183M Sell
189,685
-26,838
-12% -$25.8M 0.43% 34
2023
Q4
$190M Buy
216,523
+122,103
+129% +$107M 0.5% 25
2023
Q3
$77.7M Sell
94,420
-23,865
-20% -$19.6M 0.24% 60
2023
Q2
$85M Sell
118,285
-84,982
-42% -$61.1M 0.29% 48
2023
Q1
$167M Buy
203,267
+81,231
+67% +$66.7M 0.59% 27
2022
Q4
$88M Buy
122,036
+39,065
+47% +$28.2M 0.32% 57
2022
Q3
$57.2M Buy
82,971
+12,715
+18% +$8.76M 0.22% 84
2022
Q2
$41.5M Buy
70,256
+4,735
+7% +$2.8M 0.15% 108
2022
Q1
$45.8M Buy
65,521
+35,303
+117% +$24.7M 0.13% 120
2021
Q4
$19.1M Sell
30,218
-10,179
-25% -$6.43M 0.06% 190
2021
Q3
$24.4M Buy
40,397
+31,315
+345% +$19M 0.08% 157
2021
Q2
$5.07M Sell
9,082
-182,599
-95% -$102M 0.02% 452
2021
Q1
$90.7M Buy
191,681
+35,429
+23% +$16.8M 0.37% 35
2020
Q4
$75.5M Buy
+156,252
New +$75.5M 0.33% 49
2020
Q3
Sell
-34,668
Closed -$21.6M 1275
2020
Q2
$21.6M Buy
34,668
+33,409
+2,654% +$20.8M 0.14% 86
2020
Q1
$615K Sell
1,259
-27,029
-96% -$13.2M ﹤0.01% 575
2019
Q4
$10.6M Sell
28,288
-5,878
-17% -$2.21M 0.07% 147
2019
Q3
$9.48M Sell
34,166
-67,419
-66% -$18.7M 0.06% 146
2019
Q2
$31.8M Buy
101,585
+3,768
+4% +$1.18M 0.24% 57
2019
Q1
$40.2M Buy
97,817
+62,022
+173% +$25.5M 0.38% 43
2018
Q4
$13.4M Sell
35,795
-74,776
-68% -$27.9M 0.15% 81
2018
Q3
$44.7M Sell
110,571
-3,330
-3% -$1.35M 0.44% 30
2018
Q2
$39.3M Buy
113,901
+68,562
+151% +$23.7M 0.45% 36
2018
Q1
$15.6M Buy
45,339
+6,880
+18% +$2.37M 0.2% 84
2017
Q4
$14.5M Sell
38,459
-83,515
-68% -$31.4M 0.15% 83
2017
Q3
$54.5M Buy
+121,974
New +$54.5M 0.51% 32
2017
Q2
Sell
-760
Closed -$295K 220
2017
Q1
$295K Buy
+760
New +$295K 0.01% 164